Tradestie Institutional Equity Comparison Engine
BGM vs ETON โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ETON Overall Edge
ETON Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Eton Pharmaceutcials, Inc. Common Stock (ETON) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BGM trades at N/M Forward P/E with -23.4% operating margin (+69.8% YoY revenue) versus ETON at 18.4x Forward P/E and 31.3% operating margin (+157.9% YoY). In options structure, BGM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ETON sits in CONSOLIDATION (100th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ETON
BGM N/M vs ETON 18.4x Fwd P/E
Growth & Margin Winner
ETON
Op Margin -23.4% vs 31.3% ยท YoY +69.8% vs +157.9%
Momentum & Technical Winner
ETON
1Y -17.5% vs +261.8% ยท 52W Pos 74% vs 83%
Options & Structure Winner
ETON
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (100th %ile IV)
BGM
NASDAQ
BGM Group Ltd. Class A Ordinary Shares
Pharmaceutical Preparations
$8.00
-1.6% 1D
Market Cap
$108.6M
1M Return
-21.57%
1Y Return
-17.53%
Forward P/E
N/M
Unified AI Score
59.6 / 100
HOLD
Tech 65.0
Fund 55.0
Flow 50.0
Mom 50.0
ETON
NASDAQ
Eton Pharmaceutcials, Inc. Common Stock
Pharmaceutical Preparations
$60.85
-0.83% 1D
Market Cap
$1.8B
1M Return
+21.65%
1Y Return
+261.77%
Forward P/E
18.4x
Unified AI Score
35.9 / 100
SELL
Tech 8.0
Fund 37.0
Flow 68.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BGM -17.53%
ETON +261.77%
Spread: +270.57 pp (ETON Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BGM TTM Op. Margin: -23.4%
ETON TTM Op. Margin: 31.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BGM vs ETON. Trailing 12-month operating profitability (BGM -23.4% vs ETON 31.3%) and valuation multiples (BGM N/M vs ETON 18.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BGM | ETON | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $108.6M | $1.8B | Larger Scale | ETON |
| Trailing P/E Ratio Valuation | N/M | 39.8x | Lower Multiple | ETON |
| Forward P/E Ratio Valuation | N/M | 18.4x | Lower Multiple | ETON |
| Revenue Growth (YoY) Growth | +69.8% | +157.9% | Higher Growth | ETON |
| Operating Margin (TTM) Profitability | -23.4% | 31.3% | Higher Margin | ETON |
| Net Profit Margin Profitability | -44.2% | 35.4% | Higher Margin | ETON |
| Return on Equity (ROE) Capital Efficiency | -7.4% | 90.6% | Higher ROE | ETON |
| 52-Week Range Position Momentum | 74% ($0โ$11) | 83% ($14โ$71) | Stronger Trend | ETON |
| Beta / 30D Volatility Risk Regime | 3.69ฮฒ ยท 80% Vol | 0.71ฮฒ ยท 98% Vol | Lower Realized Risk | BGM |
| Unified Institutional Score Composite Signal | 59.6 / 100 (HOLD) | 35.9 / 100 (SELL) | Higher Composite | BGM |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BGM vs ETON Buy Guide
BGM
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ETON
CONSOLIDATION
63d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BGM nor ETON registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.